FOXE3: Forkhead Box E3 Gene in Ocular Development and Disease

Comprehensive genomic, functional, and clinical overview of FOXE3

Gene Information Card

Symbol FOXE3
Full Name Forkhead Box E3
Gene Type Protein coding
Chromosomal Location 1p33
NCBI Gene ID 2301 ncbi.nlm.nih.gov/gene/2301
Ensembl ID ENSG00000186767
UniProt ID Q13461
OMIM ID 601094
HGNC ID 3808
Aliases FKHL12, FREAC8, FOXE3

Description

FOXE3 (Forkhead Box E3) encodes a member of the forkhead family of transcription factors, characterized by a conserved DNA-binding forkhead domain. It is essential for lens and anterior segment development of the eye. FOXE3 regulates gene expression during lens placode formation, lens vesicle closure, and maintenance of lens fiber cell integrity. Mutations in FOXE3 are associated with various ocular disorders including anterior segment dysgenesis, congenital cataracts, microphthalmia, and Peters anomaly.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Anterior segment dysgenesis (ASD) Loss-of-function mutations disrupt lens and corneal development, leading to malformation of the anterior eye chamber. ClinVar, OMIM
Congenital cataracts FOXE3 mutations impair lens fiber cell differentiation and transparency, resulting in cataract formation at birth. ClinVar, OMIM
Microphthalmia Biallelic loss-of-function variants cause reduced eye size due to defective lens induction and growth. ClinVar, OMIM
Peters anomaly FOXE3 mutations contribute to corneal opacity and iridocorneal adhesions by disrupting anterior segment morphogenesis. ClinVar, OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Lens 12.5 High
Retina 4.2 Medium
Cornea 3.8 Medium
Brain 0.5 Low
Heart 0.2 Low
Cell Line Expression
Cell Line nTPM Notes
ARPE-19 (retinal pigment epithelium) 2.1 Moderate expression
HLE-B3 (human lens epithelial) 15.3 High expression
HeLa 0.3 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.240C>A (p.Tyr80*) Nonsense Rare Loss of function; truncation of forkhead domain
c.289G>A (p.Gly97Arg) Missense Rare Impaired DNA binding; dominant negative effect
c.1A>G (p.Met1?) Start loss Rare Loss of function; no protein translation
c.730C>T (p.Arg244Trp) Missense Rare Reduced transactivation activity
Mutation functional classification

Loss of Function (LOF)

Nonsense, frameshift, and start-loss mutations that abolish FOXE3 protein function, leading to recessive ocular disorders.

Gain of Function (GOF)

Not reported for FOXE3.

Dominant Negative (DN)

Missense mutations in the forkhead domain (e.g., p.Gly97Arg) that interfere with wild-type FOXE3 DNA binding and transcriptional activity, causing dominant inheritance.

Gene Ontology (GO)

• DNA-binding transcription factor activity • RNA polymerase II cis-regulatory region sequence-specific DNA binding
• regulation of transcription by RNA polymerase II • lens development in camera-type eye
• anterior segment morphogenesis • cell differentiation

Pathways

• Lens development (Reactome: R-HSA-1474244)
• Transcriptional regulation by FOXE3 (Gene Ontology)

Protein Summary

FOXE3 is a 319-amino acid transcription factor containing a highly conserved forkhead DNA-binding domain. It localizes to the nucleus and regulates target genes involved in lens fiber cell differentiation, cell cycle control, and extracellular matrix remodeling. The protein interacts with other transcription factors such as PAX6 and SOX2 to coordinate eye development. Structural integrity of the forkhead domain is critical for DNA binding; mutations in this region disrupt transcriptional activity and lead to ocular malformations.

Related Products

Product name Cat.No. Species Gene ID
FOXE3 Knockout HEK293 Cell Line EDJ-KQ3530 Human 2301 Details Get a Quote
FOXE3 Knockout HeLa Cell Line EDJ-KQ53244 Human 2301 Details Get a Quote
FOXE3 Knockout A-549 Cell Line EDJ-KQ61725 Human 2301 Details Get a Quote
FOXE3 Knockout HCT 116 Cell Line EDJ-KQ70210 Human 2301 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: